Recursion Pharmaceuticals Correlations

RXRX Stock  USD 4.55  0.18  4.12%   
The current 90-days correlation between Recursion Pharmaceuticals and Agios Pharm is 0.17 (i.e., Average diversification). The correlation of Recursion Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Recursion Pharmaceuticals Correlation With Market

Very weak diversification

The correlation between Recursion Pharmaceuticals and DJI is 0.42 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Recursion Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Recursion Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
For more information on how to buy Recursion Stock please use our How to Invest in Recursion Pharmaceuticals guide.

Moving together with Recursion Stock

  0.86HPQ HP IncPairCorr
  0.86HD Home DepotPairCorr
  0.74MSFT MicrosoftPairCorr

Moving against Recursion Stock

  0.85AMGN Amgen IncPairCorr
  0.84TRV The Travelers CompaniesPairCorr
  0.77CSCO Cisco SystemsPairCorr
  0.74FTV Fortive CorpPairCorr
  0.74XOM Exxon Mobil CorpPairCorr
  0.73MRK Merck CompanyPairCorr
  0.63CAT CaterpillarPairCorr
  0.63KO Coca Cola Sell-off TrendPairCorr
  0.59GILD Gilead SciencesPairCorr
  0.57AXP American ExpressPairCorr
  0.55BAC Bank of America Earnings Call This WeekPairCorr
  0.51MMM 3M CompanyPairCorr
  0.48JPM JPMorgan Chase Earnings Call This WeekPairCorr
  0.48IBM International BusinessPairCorr
  0.38MCD McDonaldsPairCorr

Related Correlations Analysis


Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

LQDACOGT
LQDAETNB
LQDARCUS
COGTRCUS
COGTETNB
RCUSETNB
  

High negative correlations

ETNBAGIO
LQDAAGIO
COGTAGIO
RCUSAGIO
LQDAIBRX
COGTIBRX

Risk-Adjusted Indicators

There is a big difference between Recursion Stock performing well and Recursion Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Recursion Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
AGIO  3.15 (0.35) 0.00 (0.12) 0.00 
 5.99 
 56.88 
DNLI  2.75  0.11  0.05  0.15  3.18 
 6.50 
 23.32 
ETNB  2.99  1.18  0.33 (0.65) 1.83 
 3.02 
 86.02 
BEAM  3.27  0.04  0.05  0.10  3.35 
 7.82 
 25.25 
IBRX  3.25 (0.33) 0.00 (0.08) 0.00 
 7.69 
 19.93 
RCUS  2.93  0.67  0.19  0.50  3.21 
 7.45 
 28.33 
COGT  4.78  1.63  0.60  0.50  2.21 
 6.85 
 123.47 
SRPT  3.48 (0.05) 0.01  0.07  6.51 
 6.90 
 38.88 
GLPG  1.36 (0.18) 0.00 (0.33) 0.00 
 2.31 
 13.46 
LQDA  2.99  0.50  0.13  0.62  3.40 
 8.00 
 19.63 

Recursion Pharmaceuticals Corporate Management

Najat KhanChief OfficerProfile
Kevin LeggatVice AccountingProfile
Janelle GordonVice OperationsProfile
Shafique MDInterim OfficerProfile
Lina NilssonSenior PlatformProfile